Syntax Bio

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Esphera SynBio

This synthetic biology company develops engineered exosome therapies to deliver therapeutic payloads for cancer and infectious disease treatments within the biopharmaceutical sector.

Renewal

This company develops a cell differentiation platform using synthetic embryo models to provide replacement cells and tissues for healthcare and life sciences organisations.

Stately Bio

This company develops machine learning imaging platforms and stem cell-derived therapies for biopharmaceutical researchers and clinical institutions.

clock.bio

This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.

Synteny Biotechnology

The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.

HexemBio

This company develops stem cell rejuvenation therapies using synthetic environments to treat blood cancer and age-related immune decline in human patients.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.